Partsol has come up with AI Stem Cells, a novel approach to artificial intelligence (AI) that the company claims eliminates hallucinations and errors plaguing large language models (LLMs).

The technology, detailed in a newly released video, represents a departure from conventional AI systems that rely on pattern matching and statistical prediction. According to Partsol, AI Stem Cells ground themselves in “foundational truth” before expanding to form connections across knowledge domains, addressing a critical weakness in mainstream AI: the tendency to generate plausible sounding but incorrect information.

“This is not another algorithm layered on top of a language model,” said Dr. Darryl Williams, CEO, founder and chief scientist at Partsol. “This is a new way of growing intelligence itself, one that can be trusted where failure is not an option.”

Current LLM-based AI systems have demonstrated remarkable capabilities but remain prone to generating false information — a phenomenon known as hallucination. These errors can compound over time and spread through systems, creating risks in sectors where accuracy is paramount, such as healthcare, finance, law, and scientific research.

Partsol’s approach draws an analogy to biological stem cells, which develop into specialized organs through precise guidance. Similarly, AI Stem Cells are designed to evolve through deliberate instruction rather than probabilistic processes, organizing knowledge into what the company describes as “structured systems of truth.”

The company has positioned its technology as purpose-built for high-stakes environments where conventional AI’s unpredictability presents unacceptable risks. By anchoring intelligence in verified truth before any expansion occurs, Partsol aims to prevent error replication that can silently contaminate decision-making processes.

“In every era, there is a single moment that divides history,” Williams said. “We are at the cusp of a new era, one defined not by approximation, but by certainty.”

Partsol has been developing this technology for years, working to address what many in the AI industry have come to view as an inherent limitation of language models. The company envisions applications spanning medical research, banking, legal frameworks, and national security, fields where a single hallucinated detail could have severe consequences.

The announcement comes as the AI industry grapples with questions of reliability and trustworthiness. While LLMs have revolutionized numerous applications, their tendency toward confident inaccuracy has limited adoption in certain critical sectors.

Partsol is inviting researchers, enterprises, and partners to explore the technology, positioning itself at what it calls “the frontier of this new intelligence paradigm.” The company’s stated mission of discover more, build better, and cure faster reflects its ambition to transform AI from a probabilistic tool into a deterministic system grounded in verifiable truth.